Immunic, Inc. (IMUX)
Market Open
11 Sep, 14:06
$
11. 72
-0.12
-1.0405%
$
178.58M Market Cap
- P/E Ratio
- Div Yield
34,270 Volume
-2.13 Eps
$ 11.84
Previous Close 
Want to track IMUX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Immunic, Inc. (IMUX) Statistics
Valuation metrics
Market Cap 178.58M
Enterprise value 24.05M
Trailing P/E (ttm) -2.73
Forward P/E -3.35
PEG ratio -0.03
Price/Sales (ttm) -
Price/Book (mrq) 4.37
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.22
Overview
Shares outstanding 12.04M
Float 10.49M
Shares short 1.34M
% Held by insiders 0.01%
% Held by institutions 0.44%
Average volume (10 days) 412.72K
Average volume (90 days) 194.93K
Price summary
52-Week low 5.06
52-Week high 17.43
Beta 1.37
50-Day moving average 15.02
200-Day moving average 12.12
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 27 Apr 2026
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.7%
Return on equity -1.58%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -109.48M
Net income to common (ttm) -104.29M
Diluted EPS (ttm) -2.62
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 186.63M
Total cash per share (mrq) 3.65
Total debt (mrq) 146K
Total Debt/Equity (mrq) 0
Current ratio (mrq) 5.05%
Book value per share (mrq) 3
Cash Flow
Cash flow statement -81.33M
Levered free cash flow (LFCF) -43.54M
